Candel Therapeutics CADL
NASDAQ CADL
$10.64 -0.24 (-2.21%)
As of: Sep 30, 2026 · 1:08 PM EDT

Candel Therapeutics, Inc. (CADL) Net Margin (2020 - 2022)

Updated

Candel Therapeutics (CADL) posted Net Margin of -16416.13% for Q4 2022, down 21564.52 percentage points from 5148.39% a year earlier but up 11609.68 percentage points from the prior quarter.

Analysis

Candel Therapeutics, Inc. (CADL) Net Margin (2020 - 2022) Analysis & Trends

For FY2022, Candel Therapeutics' Net Margin came in at -15040.00%, up 13859.20 percentage points from FY2021.

  • In prior years, Candel Therapeutics' Net Margin was -28899.20% in FY2021 (-14755.20 pp) and -14144.00% in FY2020.
  • Quarterly Net Margin has run from a low of -55096.77% in Q2 2021 to a high of 5148.39% in Q4 2021 over five years.
  • On a year-over-year basis, Net Margin increased in four of the last seven quarters, with an average year-over-year change of +718.89 percentage points.
  • According to Business Quant data, Net Margin for the three prior quarters was -28025.81% (Q3 2022), -13383.87% (Q2 2022) and -2903.23% (Q1 2022).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -16,416.13%
Sep 30, 2022 -28,025.81%
Jun 30, 2022 -13,383.87%
Mar 31, 2022 -2,903.23%
Dec 31, 2021 5,148.39%
Sep 30, 2021 -52,135.48%
Jun 30, 2021 -55,096.77%
Mar 31, 2021 -14,445.16%
Dec 31, 2020 -33,800.00%
Sep 30, 2020 -8,238.71%
Jun 30, 2020 -9,277.42%
API Access

Candel Therapeutics, Inc. Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=CADL&period=max&api_key=YOUR_API_KEY